AIML Innovations Announces Departure of Tim Daniels from Board of Directors
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced the immediate departure of Tim Daniels from its Board of Directors. While stepping down from the Board, Daniels will continue supporting the company in an advisory capacity.
CEO Paul Duffy acknowledged Daniels' contributions to AIML's leadership and strategic direction during his tenure, expressing appreciation for his continued involvement as an advisor. The company stated it remains focused on strengthening its leadership and advisory network to support ongoing commercialization efforts and strategic growth initiatives.
AIML operates in the artificial intelligence and machine learning sectors, focusing on digital health and wellbeing solutions through its subsidiaries NeuralCloud Solutions, Quantum Sciences, AI Rx, and strategic partnership with Health Gauge (95.2% owned by AIML).
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) ha annunciato l'immediata uscita di Tim Daniels dal suo Consiglio di Amministrazione. Pur lasciando il Consiglio, Daniels continuerà a supportare l'azienda in qualità di consulente.
Il CEO Paul Duffy ha riconosciuto il contributo di Daniels alla leadership e alla direzione strategica di AIML durante il suo mandato, esprimendo apprezzamento per il suo continuo coinvolgimento come consulente. L'azienda ha dichiarato di rimanere concentrata sul rafforzamento della sua rete di leadership e consulenza per sostenere gli sforzi di commercializzazione in corso e le iniziative di crescita strategica.
AIML opera nei settori dell'intelligenza artificiale e dell'apprendimento automatico, concentrandosi su soluzioni digitali per la salute e il benessere tramite le sue controllate NeuralCloud Solutions, Quantum Sciences, AI Rx e la partnership strategica con Health Gauge (di cui AIML detiene il 95,2%).
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) anunció la salida inmediata de Tim Daniels de su Junta Directiva. Aunque deja la Junta, Daniels continuará apoyando a la empresa en calidad de asesor.
El CEO Paul Duffy reconoció las contribuciones de Daniels al liderazgo y la dirección estratégica de AIML durante su mandato, expresando su agradecimiento por su continuo compromiso como asesor. La empresa declaró que sigue enfocada en fortalecer su red de liderazgo y asesoría para respaldar los esfuerzos de comercialización en curso y las iniciativas de crecimiento estratégico.
AIML opera en los sectores de inteligencia artificial y aprendizaje automático, enfocándose en soluciones digitales para la salud y el bienestar a través de sus subsidiarias NeuralCloud Solutions, Quantum Sciences, AI Rx y la asociación estratégica con Health Gauge (95.2% propiedad de AIML).
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)는 팀 다니엘스가 이사회에서 즉시 사임했다고 발표했습니다. 다니엘스는 이사회에서 물러나지만 자문 역할로 회사 지원을 계속할 예정입니다.
CEO 폴 더피는 다니엘스가 재임 기간 동안 AIML의 리더십과 전략적 방향에 기여한 점을 인정하며, 자문으로서 계속 참여하는 데 감사를 표했습니다. 회사는 현재 진행 중인 상업화 노력과 전략적 성장 계획을 지원하기 위해 리더십 및 자문 네트워크 강화에 집중하고 있다고 밝혔습니다.
AIML은 인공지능 및 머신러닝 분야에서 활동하며, 자회사 NeuralCloud Solutions, Quantum Sciences, AI Rx와 AIML이 95.2% 지분을 보유한 Health Gauge와의 전략적 파트너십을 통해 디지털 헬스 및 웰빙 솔루션에 주력하고 있습니다.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) a annoncé le départ immédiat de Tim Daniels de son conseil d'administration. Bien qu'il quitte le conseil, Daniels continuera à soutenir l'entreprise en tant que conseiller.
Le PDG Paul Duffy a reconnu les contributions de Daniels au leadership et à l'orientation stratégique d'AIML durant son mandat, exprimant sa gratitude pour sa participation continue en tant que conseiller. L'entreprise a déclaré qu'elle reste concentrée sur le renforcement de son réseau de leadership et de conseil afin de soutenir les efforts de commercialisation en cours et les initiatives de croissance stratégique.
AIML opère dans les secteurs de l'intelligence artificielle et de l'apprentissage automatique, en se concentrant sur des solutions numériques pour la santé et le bien-être via ses filiales NeuralCloud Solutions, Quantum Sciences, AI Rx ainsi que son partenariat stratégique avec Health Gauge (à 95,2 % détenu par AIML).
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) gab den sofortigen Rücktritt von Tim Daniels aus dem Vorstand bekannt. Obwohl er aus dem Vorstand ausscheidet, wird Daniels das Unternehmen weiterhin in beratender Funktion unterstützen.
CEO Paul Duffy würdigte Daniels' Beiträge zur Führung und strategischen Ausrichtung von AIML während seiner Amtszeit und dankte ihm für sein fortgesetztes Engagement als Berater. Das Unternehmen erklärte, dass es sich weiterhin darauf konzentriert, sein Führungs- und Beratungsnetzwerk zu stärken, um laufende Kommerzialisierungsbemühungen und strategische Wachstumsinitiativen zu unterstützen.
AIML ist in den Bereichen Künstliche Intelligenz und Maschinelles Lernen tätig und konzentriert sich auf digitale Gesundheits- und Wellnesslösungen durch seine Tochtergesellschaften NeuralCloud Solutions, Quantum Sciences, AI Rx sowie die strategische Partnerschaft mit Health Gauge (zu 95,2 % im Besitz von AIML).
- Continuation of Tim Daniels' expertise in advisory capacity maintains valuable strategic input
- Company maintains focus on commercialization efforts and strategic growth initiatives
- Loss of key board member could impact corporate governance and strategic oversight
• Tim Daniels to Continue Supporting AIML in an Advisory Capacity
VANCOUVER, BC / ACCESS Newswire / April 25, 2025 / AI/ML INNOVATIONS INC. ("AIML" OR THE "COMPANY") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that Tim Daniels has stepped down from his position on the Company's Board of Directors ("Board"), effective immediately.
Tim has been an integral part of AIML's leadership, contributing to the Company's strategic direction and governance during his tenure on the Board. His insights and dedication have played a key role in guiding AIML through important phases of growth and evolution.
Paul Duffy, CEO of AIML, commented:
"On behalf of the entire team at AIML, I would like to extend our sincere thanks to Tim for his contributions and leadership. We are pleased that Tim will continue to support the Company in an advisory capacity, where his experience and counsel will remain a valued asset as we advance our mission in AI-driven healthcare."
AIML remains focused on strengthening its leadership and advisory network to support ongoing commercialization efforts and strategic growth initiatives.
For more information about AIML:
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.
Contact:
Blake Fallis
(778) 405-0882
info@aiml-innovations.com
About AI/ML Innovations Inc. https://aiml-innovations.com/
AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its wholly owned subsidiaries, NeuralCloud Solutions Inc, Quantum Sciences Ltd, and AI Rx Inc., strategic partnerships with Health Gauge Inc. (
On behalf of the Board of Directors:
Paul Duffy, Chairman
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements - Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
SOURCE: AI/ML Innovations, Inc.
View the original press release on ACCESS Newswire
FAQ
What impact will Tim Daniels' departure from AIML's Board have on the company's operations?
What are AIML's (AIMLF) main business segments and subsidiaries?
Where is AIMLF stock traded and what are its trading symbols?
What is AIML's current business strategy in the AI healthcare sector?
